


Rosiglitazone is an anti-diabetic drug that works as an insulin sensitizer, by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin. It is marketed by the pharmaceutical company GlaxoSmithKline (GSK) as a stand-alone drug (Avandia), and in combination with metformin (Avandamet) or with glimepiride (Avandaryl).
Are you one of Avandia's victims and have suffered from:
|
|
as a result of taking Avandia? If the answer is yes, please contact us immediately by submitting the form located to the right, or by calling 1-800-940-0166.
“The Guardian” reports lawsuits over Avandia could total anywhere from $1 billion to $6 billion. Research by analysts for UBS shows that 13,000 lawsuits have been filed, with an average settlement of $50,000 per person. As of July 2010, GSK has agreed to settlements on more that 11,500 of these suits.
If you have suffered from any of the side effects listed above as a result of taking Avandia and wish to join the lawsuit against GlaxoSmithKline, please fill in the form to the right.
We take cases on a contingency basis, meaning there is no fee unless we win your case!